| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Acuvax Ltd (ASX: ACU) is in the process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. On 22 March 2013, Acuvax shareholders voted overwhlemingly to approve the acquisition of Biolife and to raise $5m to fund Phase 2 trials of the vaccine. |
| Category: | Health & biotech |
| URL: | http://www.acuvax.com.au |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | ACU |
| Year of Commencement: | 2001 |
| Address: | Suite 4, 16 Ord Street, WEST PERTH, WA, AUSTRALIA, 6005 |
| State: | Western Australia |
| Overseas Operations: | No |
| X: | |
| Facebook: | |
| Linkedin: | |
| Founders: |
No items found
|
| Awards won: | |
